Their results suggested that the number of residual ALNs and being negative for hormone receptors were strong predictors of poor outcomes, while the triple-negative type showed a trend towards early recurrence and mortality.
← all excerpts
Treatment outcome in patients with stage III breast cancer treated with neoadjuvant chemotherapy.
1
—
—